These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6339042)

  • 1. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
    Morin MJ; Bernacki RJ
    Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
    Morin MJ; Porter CW; McKernan P; Bernacki RJ
    J Cell Physiol; 1983 Feb; 114(2):162-72. PubMed ID: 6822608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.
    Kessel D
    Cancer Res; 1980 Feb; 40(2):322-4. PubMed ID: 7356515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
    Skórski T; Kawalec M
    Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of selenium on the growth of L1210 leukemic cells.
    Milner JA; Hsu CY
    Cancer Res; 1981 May; 41(5):1652-6. PubMed ID: 7214335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
    Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
    Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK; Huang AT; Joines WT
    Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antitumor activity of the bitter melon (Momordica charantia).
    Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
    Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative effect of DL-2-difluoromethylornithine on mice bearing mutant L1210 leukemia cells deficient in polyamine uptake.
    Persson L; Holm I; Ask A; Heby O
    Cancer Res; 1988 Sep; 48(17):4807-11. PubMed ID: 3136913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vivo and in vitro effects of continuous exposure of L1210 cells to 6-thioguanine.
    Maybaum J; Morgans CW; Hink LA
    Cancer Res; 1987 Jun; 47(12):3083-7. PubMed ID: 3581060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of L-canavanine against L1210 murine leukemia.
    Green MH; Brooks TL; Mendelsohn J; Howell SB
    Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.